Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Campo, Z. Kadija, M. Zorzetto, F. Mariani, G. Schmitz, M. Griese, M. Luisetti (Italy; Regensburg, Munich, Germany). Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation. Eur Respir J 2010; 36: Suppl. 54, 4184

Member's Comments

No comment yet.

Related content which might interest you: Progressive lung disease caused by ABCA3 mutation Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020 Pediatric interstitial lung disease caused by a novel ABCA3 mutation: ABCA3G964A Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009 Classification of different ABCA3 mutations causing interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations Source: Eur Respir J 2014; 43: 638-641 Year: 2013 Intersitial lung disease in chlidren with mutation in the  SFTPC and SFPTB gene: A two case report Source: International Congress 2017 – Pulmonary infection and inflammation Year: 2017 Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis Source: Eur Respir J 2015; 46: 474-485 Year: 2015 Mutations in SFTPC, SFTPA2 and TERT explain 60% of familial pulmonary fibrosis and correlate to specific disease phenotypes Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene Source: Eur Respir J 2004; 24: 30-39 Year: 2004 SFTPA mutations in interstitial lung disease (ILD) and lung cancer Source: International Congress 2017 – Rare diseases Year: 2017 Pulmonary fibrosis in non-mutation carriers of families with short telomere syndrome gene mutations. Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021 Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer Source: International Congress 2016 – IPF pathogenesis Year: 2016 Interstitial lung disease in a child heterozygous for the 1549C?GAA (121ins2) mutation of surfactant protein B Source: Eur Respir J 2011; 38: 985-987 Year: 2011 Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer Source: Eur Respir J, 56 (6) 2002806; 10.1183/13993003.02806-2020 Year: 2020 Sftpc mutations are a common cause of adult familial idiopathic interstitial pneumonia Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 First heterozygous NOP10 mutation in familial pulmonary fibrosis Source: Eur Respir J, 55 (6) 1902465; 10.1183/13993003.02465-2019 Year: 2020 Diffuse lung disease and pulmonary hypertension related to TBX4 mutation in 5 children Source: International Congress 2019 – A mixture of rare lung diseases Year: 2019 Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations Source: Eur Respir J 2011; 37: 201-204 Year: 2011 Cellular consequences of uncharacterized surfactant protein-A2 (SFTPA2)-gene mutations associated with familial IPF and lung cancer Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin Year: 2019 Genetics variants in familial interstitial pneumonia and progressive fibrosing interstitial lung disease (PF-ILD) Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021 Phenotype heterogeneity in a familial "brain lung thyroid syndrome" related to a novel NKX-2.1 mutation Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016